Cargando…
Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts
Expression of CD56 has recently been introduced as one of the adverse prognostic factors in acute promyelocytic leukemia (APL). However, the clinical significance of CD56 antigen in APL has not been well elucidated. We assessed the clinical significance of CD56 antigen in 239 APL patients prospectiv...
Autores principales: | Ono, Takaaki, Takeshita, Akihiro, Kishimoto, Yuji, Kiyoi, Hitoshi, Okada, Masaya, Yamauchi, Takahiro, Emi, Nobuhiko, Horikawa, Kentaro, Matsuda, Mitsuhiro, Shinagawa, Katsuji, Monma, Fumihiko, Ohtake, Shigeki, Nakaseko, Chiaki, Takahashi, Masatomo, Kimura, Yukihiko, Iwanaga, Masako, Asou, Norio, Naoe, Tomoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317869/ https://www.ncbi.nlm.nih.gov/pubmed/24206578 http://dx.doi.org/10.1111/cas.12319 |
Ejemplares similares
-
Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature
por: Takeshita, Akihiro, et al.
Publicado: (2020) -
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
por: Hatta, Yoshihiro, et al.
Publicado: (2018) -
Molecular Heterogeneity of the PML Gene Rearrangement in Acute Promyelocytic Leukemia: Prevalence and Clinical Significance
por: Fukutani, Hisashi, et al.
Publicado: (1993) -
Analysis of the oligomeric states of nucleophosmin using size exclusion chromatography
por: Sakashita, Gyosuke, et al.
Publicado: (2018) -
Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells
por: Chen, Fangli, et al.
Publicado: (2016)